$LBRX

$39.62 +$0.28 (0.7%) Live

$LBRX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$LBRX Management Team

Mr. Scott Garland

Independent Chairman of the Board

Age 56

Compensation $856.0K USD

Sex Male

Ms. Heather Turner

Chief Executive Officer

Member of our Board of Director

Age 52

Compensation $4.793M USD

Sex Female

Mr. Zachary Prensky

Co-Founder

Director

Age 52

Compensation $3.562M USD

Sex Male

Mr. Marc Panoff

Senior Vice President - Finance

Age 55

Compensation -

Sex Male

Mr. Richard Silva

Senior Vice President of Technical Operations

Age 58

Compensation -

Sex Male

Dr. Anna Eramo

Chief Medical Officer

Age 51

Compensation $891.1K USD

Sex Female

Mr. Gad Soffer

Chief Business Officer

Age 48

Compensation -

Sex Male

Ms. Lindsay Beaupre

Senior Vice President - People and Culture

Age -

Compensation -

Sex Female

Dr. James Rawls

Senior Vice President - Regulatory Affairs

Age -

Compensation -

Sex Male

Ms. Ellen Rose

Senior Vice President - Corporate Affairs

Age -

Compensation -

Sex Female

Name / Title	Age	Compensation	Sex
Mr. Scott Garland Independent Chairman of the Board	56	$856.0K USD	Male
Ms. Heather Turner Chief Executive Officer Member of our Board of Director	52	$4.793M USD	Female
Mr. Zachary Prensky Co-Founder Director	52	$3.562M USD	Male
Mr. Marc Panoff Senior Vice President - Finance	55	-	Male
Mr. Richard Silva Senior Vice President of Technical Operations	58	-	Male
Dr. Anna Eramo Chief Medical Officer	51	$891.1K USD	Female
Mr. Gad Soffer Chief Business Officer	48	-	Male
Ms. Lindsay Beaupre Senior Vice President - People and Culture	-	-	Female
Dr. James Rawls Senior Vice President - Regulatory Affairs	-	-	Male
Ms. Ellen Rose Senior Vice President - Corporate Affairs	-	-	Female

Board of Directors

From the proxy statement filed Apr 23, 2026

Directors

serving now

Independent

7 of 8

stated in the proxy

Average tenure

2.4 years

from year joined

CEO also chairs the board

Scott Garland

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Robert A. Lenz	55	2026 0 years	Independent	None stated	NovaBridge Biosciences	Not stated
Rebecca Luse	41	2023 3 years	Independent	None stated	None stated	$248,036
Ran Nussbaum	53	2023 3 years	Independent	None stated	None stated	$246,512
Robert R. Ruffolo, Jr.	76	2019 7 years	Independent	None stated	Elicio Therapeutics, Inc.	Not stated
Scott Garland Board chair	57	Not stated	Independent	None stated	Enliven Therapeutics, Inc.	$386,979
Heather Turner CEO	53	2024 2 years	Not independent	None stated	Terns Pharmaceuticals, Inc.	Paid as CEO
Rekha Hemrajani	56	2025 1 year	Independent	None stated	ALX Oncology Holdings Inc., MaxCyte, Inc., BioAge Labs	$252,913
William Kane	64	2025 1 year	Independent	None stated	None stated	$246,817

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 23, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$LBRX Management Team

Mr. Scott Garland

Ms. Heather Turner

Mr. Zachary Prensky

Mr. Marc Panoff

Mr. Richard Silva

Dr. Anna Eramo

Mr. Gad Soffer

Ms. Lindsay Beaupre

Dr. James Rawls

Ms. Ellen Rose

Board of Directors

Related-party transactions

No related-party transactions disclosed